Rxilient health
- Biotech or pharma, therapeutic R&D
Rxilient is a Singapore-based pharmaceutical company focusing on the emerging markets of Southeast Asia, Australia, Hong Kong, Macau, Taiwan, Middle East and Africa (MENA). Rxilient holds direct presence of in-house development, registration, supply and commercialization of global innovative products. Rxilient is incubated by CMS pharma (HK.00867) and Legend Capital.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}